Indenone derivatives:: A novel template for peroxisome proliferator-activated receptor γ (PPARγ) agonists

被引：125
作者：
Ahn, Jin Hee
Shin, Mi Sik
Jung, Sun Ho
Kang, Seung Kyu
Kim, Kwang Rok
Rhee, Sang Dal
Jung, Won Hoon
Yang, Sung Don
Kim, Seung Jun
Woo, Joo Rang
Lee, Jeong Hyung
Cheon, Hyae Gyeong [1 ]
Kim, Sung Soo
机构：
[1] Korea Res Inst Chem Technol, Bioorgan Sci Div, Taejon 305600, South Korea
[2] Korea Res Inst Biosci & Biotechnol, Taejon 305333, South Korea
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2006年 / 49卷 / 15期
关键词：
D O I：
10.1021/jm060389m
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Agonists of peroxisome proliferator-activated receptor gamma (PPAR gamma) are of interest as a treatment for diabetes, which prompted the identification of a new class of non-TZD PPAR gamma agonist. Moreover, compound 14c has displayed the most active agonistic activity with an EC50 value of 50 nM, in addition to exhibiting a new binding mode in the X-ray cocrystal structure.
引用
收藏
页码：4781 / 4784
页数：4
相关论文
共 20 条
  • [1] Benzoyl 2-methyl indoles as selective PPARγ modulators
    Acton, JJ
    Black, RM
    Jones, AB
    Moller, DE
    Colwell, L
    Doebber, TW
    MacNaul, KL
    Berger, J
    Wood, HB
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (02) : 357 - 362
  • [2] 1-PHENYLNAPHTHALENES .4. THE CYCLISATION OF METHYL HYDROGEN CIS AND TRANS-GAMMA-ORTHO-METHOXYPHENYL AND ETHYL HYDROGEN CIS AND TRANS-GAMMA-PARA-METHOXYPHENYL-GAMMA-PHENYLITACONATE TO THE CORRESPONDING 1-PHENYLSTEREOCHEMISTRY
    BADDAR, FG
    ELASSAL, LS
    BAGHOS, VB
    [J]. JOURNAL OF THE CHEMICAL SOCIETY, 1958, (MAR): : 986 - 994
  • [3] GAMMA,GAMMA-DISUBSTITUTED ITACONIC ACIDS .1. STOBBE CONDENSATION OF 1-ARYLNAPHTHYL KETONES WITH DIETHYL SUCCINATE
    BAGHOS, VB
    NASR, FH
    GINDY, M
    [J]. HELVETICA CHIMICA ACTA, 1979, 62 (01) : 90 - 100
  • [4] The mechanisms of action of PPARs
    Berger, J
    Moller, DE
    [J]. ANNUAL REVIEW OF MEDICINE, 2002, 53 : 409 - 435
  • [5] Distinct properties and advantages of a novel peroxisome proliferator-activated protein γ selective modulator
    Berger, JP
    Petro, AE
    Macnaul, KL
    Kelly, LJ
    Zhang, BB
    Richards, K
    Elbrecht, A
    Johnson, BA
    Zhou, GC
    Doebber, TW
    Biswas, C
    Parikh, M
    Sharma, N
    Tanen, MR
    Thompson, GM
    Ventre, J
    Adams, AD
    Mosley, R
    Surwit, RS
    Moller, DE
    [J]. MOLECULAR ENDOCRINOLOGY, 2003, 17 (04) : 662 - 676
  • [6] A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus
    Chilcott, J
    Tappenden, P
    Jones, ML
    Wight, JP
    [J]. CLINICAL THERAPEUTICS, 2001, 23 (11) : 1792 - 1823
  • [7] Adipose rex - Fat and fats that rule differentiation
    Demer, LL
    [J]. CIRCULATION RESEARCH, 2002, 90 (03) : 241 - 243
  • [8] Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [muraglitazar BMS-298585], a novel peroxisome proliferator-activated receptor α/γ dual agonist with efficacious glucose and lipid-lowering activities
    Devasthale, PV
    Chen, S
    Jeon, Y
    Qu, FC
    Shao, CN
    Wang, W
    Zhang, H
    Cap, M
    Farrelly, D
    Golla, R
    Grover, G
    Harrity, T
    Ma, ZP
    Moore, L
    Ren, J
    Seethala, R
    Cheng, L
    Sleph, P
    Sun, W
    Tieman, A
    Wetterau, JR
    Doweyko, A
    Chandrasena, G
    Chang, SY
    Humphreys, WG
    Sasseville, VG
    Biller, SA
    Ryono, DE
    Selan, F
    Hariharan, N
    Cheng, PTW
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 2248 - 2250
  • [9] Thiazolidinediones in type 2 diabetes mellitus - Current clinical evidence
    Diamant, M
    Heine, RJ
    [J]. DRUGS, 2003, 63 (13) : 1373 - 1405
  • [10] New solutions for type 2 diabetes mellitus - The role of pioglitazone
    Grossman, LD
    [J]. PHARMACOECONOMICS, 2002, 20 (Suppl 1) : 1 - 9
12